The frequency of germline BRCA1/2 mutation in Chinese ovarian cancer patients is 16.7–28.5%, similar to that in other Eastern Asia countries (14.6% in Japanese and 19.5% in Korean)7–9,25. The gene discussed is BRCA1; the disease is ovarian cancer.